KRYS icon

Krystal Biotech
KRYS

Overview Fund Activity

194 hedge funds and large institutions have $3.07B invested in Krystal Biotech in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 72 increasing their positions, 66 reducing their positions, and 20 closing their positions.

Holders
194
Holders Change
+6
Holders Change %
+3.19%
% of All Funds
2.84%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.07%
New
29
Increased
72
Reduced
66
Closed
20
Calls
$57.9M
Puts
$97.6M
Net Calls
-$39.7M
Net Calls Change
-$23.7M

Top Buyers

1
Jennison Associates
1
Jennison Associates
New York
$89.9M
2
Morgan Stanley
2
Morgan Stanley
New York
$79.3M
3
CS
3
Credit Suisse
Switzerland
$58.9M
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$31.8M
5
State Street
5
State Street
Massachusetts
$154M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$1.9M
2
NIP
2
Nicholas Investment Partners
California
$6.09M
3
RG
3
Redmile Group
California
$215M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$296M
5
Pictet Asset Management
5
Pictet Asset Management
Switzerland
$23.9M
Name Market Value Shares Shares
Change 		Shares
Change %
B
26
Braidwell
Connecticut
$24.3M 196,200 +118,703 +153%
Pictet Asset Management
27
Pictet Asset Management
Switzerland
$23.9M 192,875 -180,937 -48%
CWG
28
C WorldWide Group
Denmark
$23.1M 185,809 – –
Charles Schwab
29
Charles Schwab
California
$23M 185,038 +5,258 +3%
Victory Capital Management
30
Victory Capital Management
Texas
$21.4M 172,879 -36,608 -17%
BBA
31
Baker Bros. Advisors
New York
$21.1M 169,934 – –
FAM
32
Fred Alger Management
New York
$19.9M 160,335 -7,150 -4%
EAM
33
Eventide Asset Management
Massachusetts
$16.9M 136,485 +136,485 New
Handelsbanken Fonder
34
Handelsbanken Fonder
Sweden
$15.3M 123,200 +10,400 +9%
SST
35
S Squared Technology
New York
$13.7M 110,215 +2,000 +2%
RSCM
36
Rock Springs Capital Management
Maryland
$12.9M 103,969 +13,409 +15%
O
37
OrbiMed
New York
$12.9M 103,700 +103,700 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$12.2M 98,651 +431 +0.4%
Verition Fund Management
39
Verition Fund Management
Connecticut
$11.9M 95,958 -31,112 -24%
Bank of America
40
Bank of America
North Carolina
$11.3M 91,193 +27,968 +44%
IHAM
41
Integral Health Asset Management
New York
$10.5M 85,000 +15,000 +21%
Rafferty Asset Management
42
Rafferty Asset Management
New York
$10.4M 84,021 +12,215 +17%
EP
43
Eversept Partners
New York
$10M 80,798 -27,973 -26%
Schroder Investment Management Group
44
Schroder Investment Management Group
United Kingdom
$9.3M 74,945 +74,945 New
Marshall Wace
45
Marshall Wace
United Kingdom
$8.8M 70,901 +61,373 +644%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$8.33M 67,141 +11,384 +20%
DC
47
Decheng Capital
California
$8.16M 65,772 +65,772 New
Barclays
48
Barclays
United Kingdom
$7.96M 64,179 +24,659 +62%
Allspring Global Investments
49
Allspring Global Investments
North Carolina
$7.36M 59,324 +4,588 +8%
CS
50
Candriam SCA
Luxembourg
$6.82M 55,000 -15,000 -21%
1
2
3 4 5